Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - pregabalin - קפסולות - pregabalin 150 mg - pregabalin

Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - pregabalin - קפסולות - pregabalin 200 mg - pregabalin

Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - pregabalin - קפסולות - pregabalin 225 mg - pregabalin

Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - pregabalin - קפסולות - pregabalin 300 mg - pregabalin

Izrael - hebrejčina - Ministry of Health

taro international ltd, israel - pregabalin - קפסולות - pregabalin 75 mg - pregabalin

Izrael - hebrejčina - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - קרם ידיים

Izrael - hebrejčina - Ministry of Health

a.l. medi-market ltd. - noradrenaline as tartrate - תרכיז להכנת תמיסה לאינפוזיה - noradrenaline as tartrate 1 mg / 1 ml - norepinephrine

Izrael - hebrejčina - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Izrael - hebrejčina - Ministry of Health

zoetis israel holding b.v., israel - mavacoxib - טבליות לעיסות - mavacoxib 95 mg - for the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated

Izrael - hebrejčina - Ministry of Health

zoetis israel holding b.v., israel - mavacoxib - טבליות לעיסות - mavacoxib 75 mg - for the treatment of pain and inflammation associated with degenerative joint disease in dogs in cases where continuous treatment exceeding one month is indicated